The purpose of this study is to determine whether nebulized 3% hypertonic saline (HS)
improves respiratory distress in children 2-23 months presenting to the emergency department
(ED) with acute bronchiolitis with persistent respiratory distress after initial therapy with
a trial of nebulized albuterol.